Per- and polyfluoroalkyl substances (PFAS) are increasingly becoming a focal point of global concern due to their potential long-term impacts on the environment and human health. As a class of synthetic chemicals characterized by high stability and widespread applications, PFAS are facing increasingly stringent regulatory scrutiny in the cosmetics sector. This article explores the physicochemical properties and potential health risks of PFAS, and systematically reviews the evolving global regulatory landscape related to their use in cosmetics. It aims to help cosmetic enterprises gain a comprehensive understanding of regulatory requirements, mitigate compliance risks, enhance product safety, and strengthen competitiveness in international markets.

On 27 November, 2025, the United Kingdom submitted notification G/TBT/N/GBR/108 to the World Trade Organization (WTO), proposing amendments to the UK Cosmetics Regulation (EC) No 1223/2009. The proposed amendments mainly include the approval of Hexyl Salicylate by listing it as a restricted ingredient in cosmetics, as well as the prohibition of 13 substances classified as CMR (Carcinogenic, Mutagenic, or Reprotoxic). The amendments are scheduled to be officially published in February 2026, with the deadline for comments set for 26 January, 2026.

This article provides a consolidated overview of the relevant regulatory notices, supplemented by recent developments in regulatory enforcement activities-such as unannounced inspections and sampling inspections-conducted by the National Medical Products Administration (NMPA) and selected provincial and municipal authorities. The aim is to assist enterprises in staying informed of evolving regulatory trends and to reinforce awareness of quality management and compliance requirements.

On November 17, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific advice open for comment on hair dye Basic Brown 16 (C009) (SCCS/1684/25) and Basic blue 99 (C059) (SCCS/1683/25). The deadline for comments is set for January 19, 2026.

Based on data retrieved from China’s National Medical Products Administration (NMPA), three new cosmetic ingredients have successfully been filed between December 1 and December 3, 2025. Detailed information is provided in the table below. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period. As of now, a total of 152 new cosmetic ingredients have been successfully filed in 2025.

To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in November 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

On 17 November 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued preliminary opinion (SCCS/1682/25) on Butylated Hydroxyanisole (BHA) (CAS No. 25013-16-5). The deadline for comments is set for 19 January, 2026.

On November 24, 2025, the Taiwan Food and Drug Administration (TFDA) under the Ministry of Health and Welfare officially issued the testing method for Sudan dyes in cosmetics (Method No. RA03D015.001), which came into effect upon the date of publication.

In November 2025, the UK’s Scientific Advisory Group of Chemical Safety of Non-food and Non-medicinal Consumer Products (SAG-CS) issued an opinion on Hexyl Salicylate in Cosmetic Products.

To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in October 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.